METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK

FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, in particular to oncology and radiotherapy. ELISA analysis of blood serum sampled before treatment, during which levels of content of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 is carried out, and if TIMP-1 l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KLISHO ELENA VLADIMIROVNA, MUKHAMEDOV MARAT RAFKATOVICH, SHISHKIN DMITRIJ ALEKSANDROVICH, CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH, KONDAKOVA IRINA VIKTOROVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KLISHO ELENA VLADIMIROVNA
MUKHAMEDOV MARAT RAFKATOVICH
SHISHKIN DMITRIJ ALEKSANDROVICH
CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH
KONDAKOVA IRINA VIKTOROVNA
description FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, in particular to oncology and radiotherapy. ELISA analysis of blood serum sampled before treatment, during which levels of content of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 is carried out, and if TIMP-1 level is lower than 133.5 ng/ml and TIMP-2 level is lower than 88.4 ng/ml, radiotherapy is estimated as efficient, if TIMP-1 level is higher than 193.2 ng/ml and TIMP-2 level is higher than 125.9 ng/ml - absence of response to radiotherapy of squamous cell carcinomas of head and neck. ^ EFFECT: method ensures increase of efficiency of treatment of patients with malignant neoplasms of head and neck. ^ 2 ex Изобретение относится к области медицины, в частности к онкологии и лучевой терапии. Способ обеспечивает повышение эффективности лечения больных злокачественными новообразованиями головы и шеи. Проводят иммуноферментное исследование сыворотки крови, забранной до начала лечения, при котором определяют уровни содержания тканевых ингибиторов матриксных металлопротеиназ ТИМП-1 и ТИМП-2, и при уровне ТИМП-1 менее 133,5 нг/мл и уровне ТИМП-2 - менее 88,4 нг/л оценивают лучевую терапию как эффективную, а при уровне ТИМП-1 более 193,2 нг/мл и уровне ТИМП-2 более 125,9 нг/мл - отсутствие ответа на лучевую терапию плоскоклеточных карцином головы и шеи.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2408284C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2408284C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2408284C23</originalsourceid><addsrcrecordid>eNqNikEKwjAQAHvxIOof9gMFqT30umy2Jthka5oceipFIgiihfp_tNAHeBqYmW32sBy0KJAaWs_KUDDuDBIDieXV5tKyx2DEYQMelZGgf6Ltl95dI1qJHRA3DRB6Mk4sdkvTjArQKXBMl322uY_POR1W7jKoOZDO0_Qe0jyNt_RKn8HHojxWRVVScfpj-QLYdTVW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK</title><source>esp@cenet</source><creator>KLISHO ELENA VLADIMIROVNA ; MUKHAMEDOV MARAT RAFKATOVICH ; SHISHKIN DMITRIJ ALEKSANDROVICH ; CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH ; KONDAKOVA IRINA VIKTOROVNA</creator><creatorcontrib>KLISHO ELENA VLADIMIROVNA ; MUKHAMEDOV MARAT RAFKATOVICH ; SHISHKIN DMITRIJ ALEKSANDROVICH ; CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH ; KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, in particular to oncology and radiotherapy. ELISA analysis of blood serum sampled before treatment, during which levels of content of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 is carried out, and if TIMP-1 level is lower than 133.5 ng/ml and TIMP-2 level is lower than 88.4 ng/ml, radiotherapy is estimated as efficient, if TIMP-1 level is higher than 193.2 ng/ml and TIMP-2 level is higher than 125.9 ng/ml - absence of response to radiotherapy of squamous cell carcinomas of head and neck. ^ EFFECT: method ensures increase of efficiency of treatment of patients with malignant neoplasms of head and neck. ^ 2 ex Изобретение относится к области медицины, в частности к онкологии и лучевой терапии. Способ обеспечивает повышение эффективности лечения больных злокачественными новообразованиями головы и шеи. Проводят иммуноферментное исследование сыворотки крови, забранной до начала лечения, при котором определяют уровни содержания тканевых ингибиторов матриксных металлопротеиназ ТИМП-1 и ТИМП-2, и при уровне ТИМП-1 менее 133,5 нг/мл и уровне ТИМП-2 - менее 88,4 нг/л оценивают лучевую терапию как эффективную, а при уровне ТИМП-1 более 193,2 нг/мл и уровне ТИМП-2 более 125,9 нг/мл - отсутствие ответа на лучевую терапию плоскоклеточных карцином головы и шеи.</description><language>eng ; rus</language><subject>DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; SURGERY ; TESTING</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110110&amp;DB=EPODOC&amp;CC=RU&amp;NR=2408284C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110110&amp;DB=EPODOC&amp;CC=RU&amp;NR=2408284C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KLISHO ELENA VLADIMIROVNA</creatorcontrib><creatorcontrib>MUKHAMEDOV MARAT RAFKATOVICH</creatorcontrib><creatorcontrib>SHISHKIN DMITRIJ ALEKSANDROVICH</creatorcontrib><creatorcontrib>CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH</creatorcontrib><creatorcontrib>KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><title>METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK</title><description>FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, in particular to oncology and radiotherapy. ELISA analysis of blood serum sampled before treatment, during which levels of content of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 is carried out, and if TIMP-1 level is lower than 133.5 ng/ml and TIMP-2 level is lower than 88.4 ng/ml, radiotherapy is estimated as efficient, if TIMP-1 level is higher than 193.2 ng/ml and TIMP-2 level is higher than 125.9 ng/ml - absence of response to radiotherapy of squamous cell carcinomas of head and neck. ^ EFFECT: method ensures increase of efficiency of treatment of patients with malignant neoplasms of head and neck. ^ 2 ex Изобретение относится к области медицины, в частности к онкологии и лучевой терапии. Способ обеспечивает повышение эффективности лечения больных злокачественными новообразованиями головы и шеи. Проводят иммуноферментное исследование сыворотки крови, забранной до начала лечения, при котором определяют уровни содержания тканевых ингибиторов матриксных металлопротеиназ ТИМП-1 и ТИМП-2, и при уровне ТИМП-1 менее 133,5 нг/мл и уровне ТИМП-2 - менее 88,4 нг/л оценивают лучевую терапию как эффективную, а при уровне ТИМП-1 более 193,2 нг/мл и уровне ТИМП-2 более 125,9 нг/мл - отсутствие ответа на лучевую терапию плоскоклеточных карцином головы и шеи.</description><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>SURGERY</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQAHvxIOof9gMFqT30umy2Jthka5oceipFIgiihfp_tNAHeBqYmW32sBy0KJAaWs_KUDDuDBIDieXV5tKyx2DEYQMelZGgf6Ltl95dI1qJHRA3DRB6Mk4sdkvTjArQKXBMl322uY_POR1W7jKoOZDO0_Qe0jyNt_RKn8HHojxWRVVScfpj-QLYdTVW</recordid><startdate>20110110</startdate><enddate>20110110</enddate><creator>KLISHO ELENA VLADIMIROVNA</creator><creator>MUKHAMEDOV MARAT RAFKATOVICH</creator><creator>SHISHKIN DMITRIJ ALEKSANDROVICH</creator><creator>CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH</creator><creator>KONDAKOVA IRINA VIKTOROVNA</creator><scope>EVB</scope></search><sort><creationdate>20110110</creationdate><title>METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK</title><author>KLISHO ELENA VLADIMIROVNA ; MUKHAMEDOV MARAT RAFKATOVICH ; SHISHKIN DMITRIJ ALEKSANDROVICH ; CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH ; KONDAKOVA IRINA VIKTOROVNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2408284C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2011</creationdate><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>SURGERY</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>KLISHO ELENA VLADIMIROVNA</creatorcontrib><creatorcontrib>MUKHAMEDOV MARAT RAFKATOVICH</creatorcontrib><creatorcontrib>SHISHKIN DMITRIJ ALEKSANDROVICH</creatorcontrib><creatorcontrib>CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH</creatorcontrib><creatorcontrib>KONDAKOVA IRINA VIKTOROVNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KLISHO ELENA VLADIMIROVNA</au><au>MUKHAMEDOV MARAT RAFKATOVICH</au><au>SHISHKIN DMITRIJ ALEKSANDROVICH</au><au>CHOJNZONOV EVGENIJ LKHAMATSYRENOVICH</au><au>KONDAKOVA IRINA VIKTOROVNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK</title><date>2011-01-10</date><risdate>2011</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: invention relates to field of medicine, in particular to oncology and radiotherapy. ELISA analysis of blood serum sampled before treatment, during which levels of content of tissue inhibitors of matrix metalloproteinases TIMP-1 and TIMP-2 is carried out, and if TIMP-1 level is lower than 133.5 ng/ml and TIMP-2 level is lower than 88.4 ng/ml, radiotherapy is estimated as efficient, if TIMP-1 level is higher than 193.2 ng/ml and TIMP-2 level is higher than 125.9 ng/ml - absence of response to radiotherapy of squamous cell carcinomas of head and neck. ^ EFFECT: method ensures increase of efficiency of treatment of patients with malignant neoplasms of head and neck. ^ 2 ex Изобретение относится к области медицины, в частности к онкологии и лучевой терапии. Способ обеспечивает повышение эффективности лечения больных злокачественными новообразованиями головы и шеи. Проводят иммуноферментное исследование сыворотки крови, забранной до начала лечения, при котором определяют уровни содержания тканевых ингибиторов матриксных металлопротеиназ ТИМП-1 и ТИМП-2, и при уровне ТИМП-1 менее 133,5 нг/мл и уровне ТИМП-2 - менее 88,4 нг/л оценивают лучевую терапию как эффективную, а при уровне ТИМП-1 более 193,2 нг/мл и уровне ТИМП-2 более 125,9 нг/мл - отсутствие ответа на лучевую терапию плоскоклеточных карцином головы и шеи.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2408284C2
source esp@cenet
subjects DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SURGERY
TESTING
title METHOD OF PREDICTING OUTCOME OF PRE-OPERATIONAL RADIOTHERAPY OF SQUAMOUS CELL CARCINOMAS OF HEAD AND NECK
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T02%3A11%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KLISHO%20ELENA%20VLADIMIROVNA&rft.date=2011-01-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2408284C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true